Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, cross over pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fasting condition in normal, healthy, adult, human subjects.
Epistemonikos ID: da42d001fbff83f61305ce33a7ba2ecfb9468c3e
First added on: May 10, 2024